Therapeutical application of artificial beta-cell in surgery and obstetrics.
An artificial beta-cell (Biostator) was used to control blood glucose concentration in six insulin-dependent diabetics who underwent surgical procedures and in five diabetic women during both vaginal childbirth and Caesarian section. In all cases, an optimal glycometabolic control was achieved before, during, and after surgery and delivery.
D000328:Adult; D001187:Artificial Organs; D001786:Blood Glucose / Q000032:analysis; D002585:Cesarean Section; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D007515:Islets of Langerhans / Q000378:metabolism*; D007743:Labor, Obstetric; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*; D013514:Surgical Procedures, Operative
D001786:Blood Glucose; D007328:Insulin